Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid derivative class, primarily formulated as a topical ophthalmic solution to manage postoperative ocular inflammation and… Read more










Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) of the phenylacetic acid derivative class, primarily formulated as a topical ophthalmic solution to manage postoperative ocular inflammation and reduce macular edema. Pharmaceutical laboratories rely on accurate reference standards for Bromfenac, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and degradation products, to ensure product quality and regulatory compliance. These materials are essential for conducting rigorous impurity profiling, method validation, and stability studies in alignment with international pharmaceutical guidelines. Additionally, the inclusion of stable isotope labelled compounds provides critical internal standards for quantitative analytical techniques, such as liquid chromatography-mass spectrometry, to improve precision and accuracy during batch release and quality control. By utilizing these structurally characterized compounds, researchers can confidently identify unknowns, support forced degradation studies, and maintain high safety and efficacy standards throughout the pharmaceutical development and manufacturing lifecycle.